Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Universal Ibogaine Inc ( (TSE:IBO) ) has issued an update.
Universal Ibogaine Inc. has provided an update regarding its default status on financial filings and the sale of its property in Belize. The company announced a delay in the filing of its annual audited financial statements for the year ended July 31, 2024, due to the ongoing audit process. This delay necessitated a management cease trade order by the Alberta Securities Commission. The proceeds from the pending sale of the Belize property are intended to facilitate the completion of the audit. The company is committed to issuing bi-weekly default status reports until the filings are completed, and there are no anticipated defaults beyond the current situation.
More about Universal Ibogaine Inc
Universal Ibogaine Inc. is a life sciences company focused on providing ibogaine-centered addiction care. It operates in the medical sector, particularly targeting addiction treatment solutions.
YTD Price Performance: 150.0%
Average Trading Volume: 151,475
Technical Sentiment Consensus Rating: Sell
Current Market Cap: C$6.87M
See more data about IBO stock on TipRanks’ Stock Analysis page.
